Long Road Investment Counsel’s Pfizer PFE Stock Holding History

Long Road Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$366K	Hold	13,043	–	–	0.14%	69
2025 Q4	$325K	Buy	13,043 +1,000	+8%	+$25.2K	0.12%	71
2025 Q3	$307K	Hold	12,043	–	–	0.11%	71
2025 Q2	$292K	Hold	12,043	–	–	0.11%	73
2025 Q1	$305K	Buy	12,043 +4,008	+50%	+$105K	0.12%	75
2024 Q4	$213K	Hold	8,035	–	–	0.09%	70
2024 Q3	$233K	Hold	8,035	–	–	0.09%	70
2024 Q2	$225K	Hold	8,035	–	–	0.1%	69
2024 Q1	$223K	Hold	8,035	–	–	0.09%	69
2023 Q4	$218K	Hold	8,035	–	–	0.09%	67
2023 Q3	$267K	Hold	8,035	–	–	0.13%	64
2023 Q2	$295K	Hold	8,035	–	–	0.14%	63
2023 Q1	$328K	Sell	8,035 -1,000	-11%	-$43.2K	0.16%	63
2022 Q4	$463K	Sell	9,035 -8,000	-47%	-$384K	0.23%	62
2022 Q3	$745K	Hold	17,035	–	–	0.41%	51
2022 Q2	$893K	Buy	17,035 +4,483	+36%	+$228K	0.46%	50
2022 Q1	$650K	Sell	12,552 -4,219	-25%	-$219K	0.29%	58
2021 Q4	$990K	Hold	16,771	–	–	0.39%	50
2021 Q3	$721K	Hold	16,771	–	–	0.32%	57
2021 Q2	$657K	Hold	16,771	–	–	0.29%	58
2021 Q1	$608K	Hold	16,771	–	–	0.27%	58
2020 Q4	$617K	Buy	16,771 +3,819	+29%	+$140K	0.3%	57
2020 Q3	$451K	Sell	12,952 -9,995	-44%	-$350K	0.25%	58
2020 Q2	$712K	Hold	22,947	–	–	0.42%	52
2020 Q1	$711K	Buy	22,947 +15,265	+199%	+$520K	0.51%	48
2019 Q4	$286K	Sell	7,682 -15,265	-67%	-$544K	0.17%	61
2019 Q3	$782K	Sell	22,947 -527	-2%	-$19.2K	0.45%	52
2019 Q2	$965K	Hold	23,474	–	–	0.57%	47
2019 Q1	$946K	Buy	+23,474	New	+$940K	0.58%	47
2018 Q4	–	Sell	-7,155	Closed	-$299K	–	69
2018 Q3	$299K	Hold	7,155	–	–	0.2%	63
2018 Q2	$246K	Hold	7,155	–	–	0.17%	64
2018 Q1	$241K	Hold	7,155	–	–	0.17%	69
2017 Q4	$246K	Hold	7,155	–	–	0.17%	69
2017 Q3	$242K	Hold	7,155	–	–	0.17%	73
2017 Q2	$228K	Hold	7,155	–	–	0.17%	70
2017 Q1	$232K	Hold	7,155	–	–	0.17%	68
2016 Q4	$220K	Hold	7,155	–	–	0.17%	68
2016 Q3	$230K	Hold	7,155	–	–	0.18%	66
2016 Q2	$239K	Hold	7,155	–	–	0.19%	66
2016 Q1	$201K	Hold	7,155	–	–	0.16%	70
2015 Q4	$219K	Hold	7,155	–	–	0.18%	65
2015 Q3	$213K	Hold	7,155	–	–	0.18%	65
2015 Q2	$228K	Hold	7,155	–	–	0.19%	63
2015 Q1	$236K	Hold	7,155	–	–	0.2%	62
2014 Q4	$211K	Buy	+7,155	New	+$205K	0.19%	63

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Long Road Investment Counsel's PFE Position: Q1 2026 in Review

Long Road Investment Counsel held its Pfizer (PFE) position steady in Q1 2026 at 13,043 shares worth $366K. The position accounts for 0.14% of the portfolio, ranked #69.

Long Road Investment Counsel first reported a position in PFE in Q4 2014 and has held it in 45 quarters since. The position peaked at $990K in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Long Road Investment Counsel held 13,043 shares of Pfizer worth $366K as of Q1 2026.
Long Road Investment Counsel left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 0.14% of Long Road Investment Counsel's portfolio in Q1 2026, its #69 holding.
Long Road Investment Counsel first reported a position in Pfizer in Q4 2014 and has held it in 45 quarters since.
Long Road Investment Counsel's Pfizer position peaked at $990K in Q4 2021.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Long Road Investment Counsel's 13F filing for Q1 2026, filed 8 May 2026.